Medication Adherence Initiatives — Part II

Bova CA Fennie KP Knafl DG Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav 2005;9:103–10.

Escobar I Campo M Martin J Factors affecting patient adherence to highly active antiretroviral therapy. Ann Pharmacother 2003;37:775–81.

Parker-Wylie L . Practical innovation boosts adherence in HIV patients. Journal of Pharmacy Practice 2005;21(11):45.

Inciardi JF Leeds AL . Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus. Pharmacother 2005;25(6):790–6.

Mills E Nachega J Buchan I Adherence to antiretroviral therapy in Africa versus North America: a meta-regression analysis. XVI International AIDS Conference, Toronto, ON, 13–18 August 2006. Abstract no. TUPDB03.

Chiou PY Kuo BI Lee MB A programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients. J Adv Nurs 2006;55(2):169–79.

Bangsberg DR . Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939–41.

Kane SV . Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006;23(5):577–85.

Diaz E Woods SW Rosenheck RA . Effects of ethnicity on psychotropic medication adherence. Community Med Health J 2005;41:521–37.

Pratt SI Mueser KT Driscoll M Medication nonadherence in older people with serious mental illness: prevalence and correlates. Psychiatr Rehabil J 2006;29(4):299–310.

Byrne N Livingston G Regan C . Adherence to treatment in mood disorders. Curr Opin Psychiatry 2006;19(1):44–9.

Farzad A Laurin MY Larivière C The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol 2003;10(3):101–6.

Perreault S Blais L Dragomir A Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol 2005;61:667–74.

Lachaîne J Rinfret S Merikle E P Tarride JE . Persistence and adherence to cholesterol-lowering agents: evidence from Régie de l'sAssurance Maladie du Québec data. Am Heart J 2006;152:164–9.

Benner JS Pollack MF Smith TW Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy. Am J Health Syst Pharm 2005;62:1468–75.

Blackburn DF Dobson RT Blackburn JL Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 2005;21(6):485–8.

Blackburn DF Dobson RT Blackburn JL Wilson TW . Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacother 2005;25(8):1035–43.

Peterson AM Takiya L Finley R . Meta-analysis of interventions to improve drug adherence in patients with hyperlipidemia. Pharmacother 2003;23(1):80–7.

Malone M Alher-Mayer SA . Pharmacist intervention enhances adherence to orlistat therapy. Ann Pharmacother 2003;37:1598–1602.

Silverman SL Gold DT . Compliance with osteoporosis medications: challenges for healthcare providers. Medscape OB/Gyn & Women's Health 2005;10(1). Available: www.medscape.com (accessed July 30, 2007).

Prochaska JO Velicer WF Rossi JS . Stages of change and decisional balance for 12 problem behaviours. Health Psychol 1994;13(1):39–46.

Simpson SH Eurich DT Majumdar SR A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333(7557):15.

Rasmussen JN Chong A Alter DA . Relation between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177–86.

Ho PM Rumsfeld JS Masoudi FA Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836–41.

Ho PM Spertus JA Masoudi FA Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Inter Med 2006;166:1842–7.

Lee JK Grace KA Taylor AJ . Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol. JAMA 2006;296:2563–71.

Osterberg L Blaschke T . Adherence to medication. N Engl J Med 2005;353:487–97.

McLean W . An adherence study of prescription refill data, with and without a periodic patient education program. Can Pharm J 2007;140(2):104–6.

Garnett WR Davis LJ McKenney JM . Effect of telephone follow-up on medication compliance. Am J Hosp Pharm 1981;38:676–9.

Beaucage K Lachance-Demers H Ngo TT Telephone follow-up of patients receiving antibiotic prescriptions from community pharmacies. Am J Health Syst Pharm 2006;63(6): 557–63.

Wu JYF Leung WYS Chang S Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006. Available: www.bmj.com/cgi/content/abstract/bmj.38905.447118.2Fv1.

Schnipper JL Kirwin JL Cotugno MC Role of pharmacist counselling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166:565–71.

Tsuyuki RT Johnson JA Teo KK A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002;162:1149–55.

De Young M . Research on the effects of pharmacist-patient communication in institutions and ambulatory care sites, 1969–1994. Am J Health Syst Pharm 1996;53:1277–91.